CAMP4 Therapeutics Corp. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 6.31 M | $38.81 M | 35.91% | 31.29% |
| 5AM VENTURE MANAGEMENT, LLC | 02/17/2026 | 5.87 M | $35.98 M | 0.00% | 29.11% |
| FMR LLC | 02/17/2026 | 4.92 M | $30.15 M | 62.67% | 24.40% |
| VIVO CAPITAL, LLC | 02/13/2026 | 4.25 M | $26.03 M | 8.29% | 21.06% |
| ENAVATE SCIENCES GP, LLC | 02/17/2026 | 3.04 M | $18.61 M | -19.81% | 15.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 2.44 M | $14.94 M | 100.00% | 12.09% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 2.18 M | $13.37 M | 11.27% | 10.82% |
| AH CAPITAL MANAGEMENT, L.L.C. | 02/17/2026 | 2.13 M | $13.03 M | 0.00% | 10.54% |
| 02/17/2026 | 1.98 M | $12.16 M | 100.00% | 9.84% | |
| VANGUARD GROUP INC | 01/29/2026 | 1.67 M | $10.26 M | 433.63% | 8.30% |
| HARBOURVEST PARTNERS LLC | 02/17/2026 | 1.27 M | $7.80 M | 0.00% | 6.31% |
| BLACKROCK, INC. | 02/12/2026 | 390.16 K | $2.39 M | 3,311.38% | 1.94% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 336.29 K | $2.06 M | 457.04% | 1.67% |
| ECOR1 CAPITAL, LLC | 02/17/2026 | 325.00 K | $1.99 M | 100.00% | 1.61% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/13/2026 | 228.89 K | $1.40 M | 100.00% | 1.14% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/13/2026 | 200.00 K | $1.23 M | 0.00% | 0.99% |
| 683 CAPITAL MANAGEMENT, LLC | 02/17/2026 | 126.36 K | $774.61 K | 100.00% | 0.63% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 94.53 K | $579.48 K | -2.92% | 0.47% |
| VICTORY CAPITAL MANAGEMENT INC | 02/13/2026 | 82.79 K | $507.50 K | 0.00% | 0.41% |
| NORTHERN TRUST CORP | 02/17/2026 | 74.51 K | $456.74 K | 409.81% | 0.37% |
| BARCLAYS PLC | 02/13/2026 | 73.60 K | $451.17 K | 105,044.29% | 0.37% |
| STATE STREET CORP | 02/13/2026 | 39.70 K | $243.36 K | 52.69% | 0.20% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 34.72 K | $212.83 K | 100.00% | 0.17% |
| JANE STREET GROUP, LLC | 02/12/2026 | 25.53 K | $156.52 K | 100.00% | 0.13% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 25.00 K | $153.25 K | 0.00% | 0.12% |
| CITIGROUP INC | 02/13/2026 | 21.40 K | $131.20 K | 100.00% | 0.11% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 18.82 K | $115.39 K | 100.00% | 0.09% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 18.80 K | $115.24 K | 100.00% | 0.09% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 18.72 K | $114.74 K | 100.00% | 0.09% |
| MARINER, LLC | 02/13/2026 | 15.37 K | $94.22 K | -11.14% | 0.08% |
| JEFFERIES FINANCIAL GROUP INC. | 02/09/2026 | 11.36 K | $69.64 K | 100.00% | 0.06% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 10.10 K | $61.93 K | -89.37% | 0.05% |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 01/29/2026 | 10.00 K | $61.30 K | 100.00% | 0.05% |
| MORGAN STANLEY | 02/13/2026 | 9.91 K | $60.77 K | 330,366.67% | 0.05% |
| UBS GROUP AG | 01/29/2026 | 5.15 K | $31.54 K | -26.95% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 406 | $2.49 K | -92.81% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 33 | $202 | -57.69% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 22 | $135 | -92.23% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 10 | $61 | -33.33% | 0.00% |
| ROYAL BANK OF CANADA | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CAMP4 Therapeutics Corp. institutional Ownership - FAQ's
During the previous two years, 96 institutional investors and hedge funds held shares of CAMP4 Therapeutics Corp.. The most heavily invested institutionals were:
JANUS HENDERSON GROUP PLC: 6.31 M
5AM Venture Management, LLC: 5.87 M
FMR LLC: 4.92 M
Vivo Capital, LLC: 4.25 M
Enavate Sciences GP, LLC: 3.04 M
BALYASNY ASSET MANAGEMENT L.P.: 2.44 M
189.72% of CAMP4 Therapeutics Corp. stock is owned by institutional investors.
Institutional investors have bought a total of 44.12 M shares in the last 24 months. This purchase volume represents approximately $277.07 M in transactions.